Research Paper Volume 16, Issue 1 pp 518—537
New perspectives on the potential of tetrandrine in the treatment of non-small cell lung cancer: bioinformatics, Mendelian randomization study and experimental investigation
Figure 9. The effect of tetrandrine treatment on NSCLC cells. (A, B) NSCLC cells were subjected to several concentrations of tetrandrine treatment and the cell viability was measured by CCK-8 assay; (C, D) Cell proliferation of NSCLC cells were conducted by 5-ethynyl-2′-deoxyuridine (EdU) incorporation assay; (E, F) NSCLC cells were subjected to tetrandrine treatment (10 μm, 24 h) and followed by Annexin V-FITC/PI assay. *P < 0.05, **P < 0.01, ***P < 0.001 versus control.